The 2021 session of the Colorado General Assembly ended June 8, following a packed calendar that saw the session draw to a close later than usual because of COVID-19 precautions. […]
This Colorado Consortium for Prescription Drug Abuse Prevention’s response to joining Telligen to address high priority health issues during COVID-19 and beyond has demonstrated a high level of commitment toward […]
Though it may be simpler to focus on the alarming and growing numbers of individuals experiencing a substance use disorder or losing their lives from an overdose, we must remember […]
The last possible day for the 2021 legislative session is June 12. While there were hopes for the session to end late May, many anticipate session to close June 11. […]
The Colorado General Assembly is past the midway point of its 2021 session, and lawmakers continue to work on a number of bills related to addressing the opioid crisis and […]
On April 1st, the White House Office of National Drug Control and Policy announced seven priorities of the Biden-Harris administration for addressing the nation’s overdose and addiction crisis. The Administration’s […]
By José Esquibel Currently, four bills have been introduced in the current legislative session related to opioids and other substance use disorders. Here are brief summaries of the bills. This is […]
The Consortium is very pleased to announce the Grant Writing Assistance Program is resuming starting April 1, 2021! In 2019 and 2020, this program helped 23 organizations win a combined […]
By José Esquibel The Biden-Harris Administration has released information on the priorities of the Office of National Control Policy (ONDCP). There is recognition that the COVID-19 pandemic has exacerbated the addiction […]
By José Esquibel In early February, McKinsey & Co., a major consulting firm, finalized a settlement agreement with 43 states, the District of Columbia and three territories for its role […]